Lantheus Holdings, Inc. stock analysis
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceuti
- Ticker
- LNTH
- Exchange
- Nasdaq
- Sector
- Health Care
- Industry
- Health Care Equipment & Services
What should I review before buying Lantheus Holdings, Inc. stock?
Compare valuation with reported financial performance, inspect the price history, and weigh the evidence for and against the investment case. Review the risks and assumptions before making your own decision.
Inside the full analysis
- Valuation
- Growth
- Financial health
- Ownership
- Research
Sign in to open the full analysis. Paid plans use included reports first, then 50 credits per additional report. Reports outside your included market also cost 50 credits. Credit access lasts 72 hours, including revisits.
Sign in to open the analysis